All areas of thalassemia research have sustained major advances following the Ninth Cooley's Anemia Symposium (2009). The 2015 symposium brought together basic scientists, clinical investigators, and clinicians for interactions and education. Areas of focus included the biology of globin gene regulation and fetal hemoglobin induction, the evolving areas of stem cell transplant, gene therapy strategies and gene editing, the biology of iron regulation and possible therapeutic interventions in the hepcidin regulatory system, and clinical issues in thalassemia treatment and imaging. Leading investigators, together with physicians involved in thalassemia care from around the world, were featured speakers. Interactive poster sessions allowed trainees involved in all of these research areas to present their work.
Ever since the inaugural meeting, jointly presented by the Cooley's Anemia Foundation and the academy in 1964, this series of symposia convened at five–six year intervals has been the preeminent forum for convening the thalassemia research community, the pharmaceutical industry, and funding agencies dedicated to fighting this blood disorder. The 2015 meeting carried on this proud tradition.
Abstracts
- "An Exploratory Analysis of the Complement System in β-Thalassemia Major"
John Chapin, M.D., Hunter Terry, Dorothy Kleinert, N.P., Sujit Sheth, M.D., Patricia-Jane Giardina, M.D. and Jeffrey Laurence, M.D. - "New Hepatitis C Treatments Are Safe and Effective in Transfusion-Dependent Thalassemia"
John Chapin, M.D., Dorothy Kleinert, N.P., Sujit Sheth, M.D. and Patricia-Jane Giardina, M.D. - "A Pilot Study of PROMIS and Patient Reported Outcomes in Thalassemia"
John Chapin, M.D., Dorothy Kleinert, N.P., Lisa A. Mandl, M.D., M.P.H., Sujit Sheth M.D. and Patricia-Jane Giardina, M.D. - "Pregnancy in Thalassemia: A Decade of Experience at the NewYork-Presbyterian/Weill Cornell Medical Center"
Dorothy Kleinert, A.N.P., M.P.H., M.A., C.P.N.P., John Chapin, M.D., Sujit Sheth, M.D. and Patricia Jane Giardina, M.D.